National Institute of Allergy and Infectious Diseases
National Institutes of Health

Search
	Advanced Search

Help | Site Index | Contact Us

Biodefense and Related Programs
Biodefense
About
For Researchers
Public and Media
Biosafety Labs
Lab Tour
Congressional Testimony
Fact Sheets
News Releases
Related Links
Radiation Countermeasures
Chemical Countermeasures

Biodefense

News Releases

2007

April 18, 2007

Plan for Development and Purchase of Medical Countermeasures

2006

Sept. 25, 2006	NIAID Awards $4 Million to Develop Anti-Radiation Treatments
July 12, 2006	New NIAID Program Aims to Model Immune Responses and Key Infectious Diseases
May 3, 2006	NIH Dedicates the C.W. Bill Young Center for Biodefense and Emerging Infectious Diseases
April 26, 2006	Vaccine Given Post-Exposure Protects Monkeys Against Deadly Marburg Virus
April 23, 2006	Scientists Design Potent Anthrax Toxin Inhibitor
Jan. 23, 2006	Mice Studies Illustrate Potential of Chimp/Human Antibodies to Protect Against Smallpox

2005

Oct. 12, 2005	NIAID Awards $47 Million in New Effort to Develop Medical Countermeasures Against Radiological and Nuclear Threats
Oct. 3, 2005	Large Tularemia Vaccine Contracts Among New NIAID Biodefense Awards
July 6, 2005	Scientists Discover How Nipah Virus Enters Cells
June 27, 2005	Cancer Drug Slows Poxvirus in Mice
June 1, 2005	New NIAID Grants Strengthen National Biodefense and Emerging Infectious Diseases Research Network
Feb. 1, 2005	New Way To Block Pox Shows Promise In Lab Study

2004

Nov. 1, 2004	NIAID Launches Program to Improve Medical Tools Against Emerging Infectious Diseases
Oct. 12, 2004	New Study on Smallpox in Monkeys Reveals Tactics of a Killer
Oct. 7, 2004	HHS Awards $232 Million in Biodefense Contracts for Vaccine Development
July 4, 2004	3-D Structure of Anthrax Toxin Complex Solved
May 19, 2004	NIAID Forms Network to Tackle Potentially Fatal Reaction to Smallpox Vaccine
March 24, 2004	Mouse Model Mimics Real-World Plague Infection
March 10, 2004	Effectiveness of Safer Smallpox Vaccine Demonstrated Against Monkeypox

2003

Nov. 18, 2003	NIAID Ebola Vaccine Enters Human Trial
Sept. 30, 2003	NIAID Funds Construction of Biosafety Laboratories
Sept. 29, 2003	NIAID Reports 'Tremendous Progress' in Biodefense Research
Sept. 17, 2003	$85 Million Awarded for Research on Human Immunity and Biodefense
Sept. 4, 2003	HHS Announces New Regional Centers for Biodefense Research
Sept. 2, 2003	Mouse Study Gives New View of Anthrax Toxin
Aug. 6, 2003	Fast-Acting Ebola Vaccine Protects Monkeys
April 30, 2003	Anthrax Genome Decoded
Feb. 25, 2003	HHS Announces Contracts To Develop Safer Smallpox Vaccines
Jan. 8, 2003	Powerful Technologies Probe Innate Immunity

2002

Oct. 17, 2002	Dr. Marshall Bloom Named Associate Director of Rocky Mt. Laboratories
Oct. 15, 2002	USAMRIID-NIAID Announce Research Partnership at Fort Detrick
Oct. 3, 2002	HHS Announces Contracts for Developing a New Anthrax Vaccine
June 11, 2002	NIAID Expands Vaccine Testing Network
May 9, 2002	Researchers Unravel Anthrax Genome
April 25, 2002	Single Gene Leap Led to Flea-Borne Transmission of Plague Bacterium
March 28, 2002	NIAID Study Results Support Diluting Smallpox Vaccine Stockpile to Stretch Supply
March 14, 2002	NIAID Unveils Counter-Bioterrorism Research Agenda

2001

Dec. 6, 2001	HHS Accelerates Bioterrorism Research
Oct. 23, 2001	NIAID-supported Anthrax studies appearing in the journal Nature

2000

Nov. 29, 2000

Novel Vaccine Protects Monkeys from Ebola Infection

E-mail this page

Print this page